Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Creative Life Science CoROCO:7837 +2.75%20 EV-to-FCF is 20.00 as of Jul. 21, 2026, which is 41% above its 10-year median of 14.18. GuruFocus rates ROCO:7837 with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 338 Biotechnology companies, Creative Life Science Co ranks worse than 57.1% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Creative Life Science Co's Enterprise Value is NT$1,640 Mil.
Creative Life Science Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$82 Mil. Therefore, Creative Life Science Co's EV-to-FCF for today is 20.00.
The historical rank and industry rank for Creative Life Science Co's EV-to-FCF or its related term are showing as below:
ROCO:7837'
s EV-to-FCF Range Over the Past 10 Years
Min: 12.78 Med: 14.18 Max: 32.86
Current: 20.28
During the past 5 years, the highest EV-to-FCF of Creative Life Science Co was 32.86. The lowest was 12.78. And the median was 14.18.
ROCO:7837's EV-to-FCF is ranked worse than 57.1% of 338
companies
in the Biotechnology industry
Industry Median: 15.02
vs ROCO:7837: 20.28
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Creative Life Science Co (ROCO:7837) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Creative Life Science Co's PE Ratio (TTM) for today is calculated as:
Creative Life Science Co's share price for today is NT$71.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Creative Life Science Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$5.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Creative Life Science Co EV-to-FCF Related Terms
Creative Life Science Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7837 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, Creative Life Science Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creative Life Science Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Creative Life Science Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Creative Life Science Co's EV-to-FCF falls into.
Creative Life Science Co's current Enterprise Value is NT$1,640 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Creative Life Science Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creative Life Science Co (ROCO:7837) has a EV-to-FCF of 20.00 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Creative Life Science Co and its competitors. This is 41% above median its historical median of 14.18. Over the past decade, Creative Life Science Co's EV-to-FCF has ranged from 12.78 to 32.86. According to the industry distribution chart, Creative Life Science Co ranks #193 out of 338 companies in the Biotechnology industry, placing it in the top 57.1%.
Is Creative Life Science Co's EV-to-FCF too high?
Creative Life Science Co's current EV-to-FCF of 20.00 is 41% above median its 10-year median of 14.18. Over the past 10 years, this metric has ranged from a low of 12.78 to a high of 32.86. The Biotechnology industry median EV-to-FCF is 15.02. Creative Life Science Co's value of 20.00 is 33.2% above this industry median. Based on the distribution chart, Creative Life Science Co ranks #193 out of 338 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Creative Life Science Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Creative Life Science Co ranks #193 out of 338 companies for EV-to-FCF. This places Creative Life Science Co in the lower half of its industry. The industry median EV-to-FCF is 15.02. Creative Life Science Co's value of 20.00 is 33.2% above this benchmark. Historically, Creative Life Science Co's own EV-to-FCF has ranged from 12.78 to 32.86 over the past decade. While the company's 10-year median is 14.18 vs. the industry median of 15.02, Creative Life Science Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.02, based on 338 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Creative Life Science Co's current EV-to-FCF of 20.00 is 33.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Creative Life Science Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Creative Life Science Co's current EV-to-FCF is 20.00, which is 41% above median its own 10-year median of 14.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current EV-to-FCF of 20.00. The current EV-to-FCF is 20.00, which is 41% above median its 10-year median of 14.18 and 33.2% above the Biotechnology industry median of 15.02. Creative Life Science Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current EV-to-FCF is 20.00 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
20GF Score
Get the complete analysis for ROCO:7837
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7837 has been successfully added to your 
